ATPW
CYTK icon

Ashton Thomas Private Wealth’s Cytokinetics CYTK Stock Holding History

Ashton Thomas Private Wealth’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-132
Closed -$7.15K – 897
2024
Q2 		$7.15K Buy
+132
New +$7.97K ﹤0.01% 1432

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Ashton Thomas Private Wealth's CYTK Position: Q3 2024 in Review

Ashton Thomas Private Wealth sold out of Cytokinetics (CYTK) in Q3 2024, closing a stake of 132 shares — an estimated $7.15K sold.

Ashton Thomas Private Wealth first reported a position in CYTK in Q2 2024 and held it in 1 quarter. The position peaked at $7.15K in Q2 2024. 347 funds tracked by Wall St. Rank hold CYTK as of Q3 2024.

  • Ashton Thomas Private Wealth reported no remaining Cytokinetics position as of Q3 2024 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 132 Cytokinetics shares in Q3 2024, an estimated $7.15K.
  • Ashton Thomas Private Wealth first reported a position in Cytokinetics in Q2 2024 and held it in 1 quarter.
  • Ashton Thomas Private Wealth's Cytokinetics position peaked at $7.15K in Q2 2024.
  • 347 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2024.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2024, filed 5 Nov 2024.